(Q42469928)

1 November 2017

title

Soluble interleukin 2 receptor (sIL2R) in monitoring advanced lung cancer during chemotherapy (English)

1 reference

1 November 2017

Brunetti G

1

1 reference

1 November 2017

Bossi A

2

1 reference

1 November 2017

Baiardi P

3

1 reference

1 November 2017

Jedrychowska I

4

1 reference

1 November 2017

Pozzi U

5

1 reference

1 November 2017

Bacchella L

6

1 reference

1 November 2017

Bernardo G

7

1 reference

1 November 2017

publication date

1 January 1999

1 reference

1 November 2017

1 reference

1 November 2017

volume

23

1 reference

1 November 2017

issue

1

1 reference

1 November 2017

page(s)

1-9

1 reference

Soluble interleukin 2 receptor in lung cancer. An indirect marker of tumor activity?

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

The clinical significance of serum soluble interleukin-2 receptors in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

The biological significance of soluble interleukin-2 receptors in solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

Postoperative increase in soluble interleukin-2 receptor serum levels as predictor for early recurrence in non-small cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

Serum levels of soluble interleukin-2 receptors and their relation to lymphocyte subpopulations in patients with metastatic solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

Cytokine production and serum levels in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

Lymphocyte subsets, sIL2-R and sICAM-1 in blood during allergen challenge tests in asthmatic children.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

Interleukin-2 and soluble interleukin-2 receptor in bronchoalveolar lavage fluid from patients with bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

Serum soluble interleukin-2 receptor: a useful indicator of the clinical course in pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

Soluble interleukin-2 receptor and cellular profiles in bronchoalveolar lavage fluid from patients with bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

Concomitant modulation of serum-soluble interleukin-2 receptor and alveolar macrophage interleukin-2 receptor in sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

Increased levels of soluble serum interleukin-2 receptor in extrinsic allergic alveolitis correlate with interleukin-2 receptor expression on alveolar macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

Interleukin-2 receptors in pulmonary adenocarcinoma tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0169-5002%2898%2900094-4

7 January 2021

10.1016/S0169-5002(98)00094-4

Identifiers

DOI

1 reference

1 November 2017

1 reference